HU207043B - Process for producing sulfonamide derivatives and pharmaceutical compositions comprising such compounds - Google Patents

Process for producing sulfonamide derivatives and pharmaceutical compositions comprising such compounds Download PDF

Info

Publication number
HU207043B
HU207043B HU884430A HU443088A HU207043B HU 207043 B HU207043 B HU 207043B HU 884430 A HU884430 A HU 884430A HU 443088 A HU443088 A HU 443088A HU 207043 B HU207043 B HU 207043B
Authority
HU
Hungary
Prior art keywords
formula
compound
group
compounds
alkyl
Prior art date
Application number
HU884430A
Other languages
English (en)
Hungarian (hu)
Other versions
HUT48587A (en
Inventor
Hitoshi Oinuma
Motosuke Yamanaka
Kazutoshi Miyake
Tomonori Hoshiko
Norio Minami
Tadao Shoji
Yoshiharu Daiku
Kohei Sawada
Kenichi Nomoto
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP20972687A external-priority patent/JP2637989B2/ja
Priority claimed from JP62209728A external-priority patent/JP2584454B2/ja
Priority claimed from JP20972787A external-priority patent/JPH0819083B2/ja
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of HUT48587A publication Critical patent/HUT48587A/hu
Publication of HU207043B publication Critical patent/HU207043B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/54—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU884430A 1987-08-24 1988-08-23 Process for producing sulfonamide derivatives and pharmaceutical compositions comprising such compounds HU207043B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP20972687A JP2637989B2 (ja) 1987-08-24 1987-08-24 ピペリジン誘導体及びそれを含有する不整脈治療・予防剤
JP62209728A JP2584454B2 (ja) 1987-08-24 1987-08-24 ピペリジン誘導体及びそれを含有する不整脈治療・予防剤
JP20972787A JPH0819083B2 (ja) 1987-08-24 1987-08-24 スルホンアミド誘導体及びそれを含有する不整脈治療・予防剤

Publications (2)

Publication Number Publication Date
HUT48587A HUT48587A (en) 1989-06-28
HU207043B true HU207043B (en) 1993-03-01

Family

ID=27329045

Family Applications (1)

Application Number Title Priority Date Filing Date
HU884430A HU207043B (en) 1987-08-24 1988-08-23 Process for producing sulfonamide derivatives and pharmaceutical compositions comprising such compounds

Country Status (11)

Country Link
US (2) US4977165A (el)
EP (1) EP0304888B1 (el)
KR (1) KR910002581B1 (el)
CA (1) CA1263658A (el)
DE (1) DE3875866T2 (el)
DK (1) DK470488A (el)
ES (1) ES2045044T3 (el)
GR (1) GR3006380T3 (el)
HU (1) HU207043B (el)
NO (1) NO883750L (el)
PH (1) PH25458A (el)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4906634A (en) * 1988-03-08 1990-03-06 Schering A.G. Novel N-[4-(aminosubstituted)phenyl]methanesulfonamides and their use as cardiovascular agents
JP3065659B2 (ja) * 1989-07-25 2000-07-17 ファルマシア・アンド・アップジョン・カンパニー 抗不整脈性第三級アミン―アルケニル―フェニル―アルカンスルホンアミド
US5405997A (en) * 1989-07-25 1995-04-11 The Upjohn Company Antiarrhythmic methanesulfonamides
ES2096651T3 (es) * 1990-06-07 1997-03-16 Merrell Pharma Inc Derivados de 1-piperidinil alcanoilarilsulfonamida.
US5478846A (en) * 1990-06-07 1995-12-26 Merrell Dow Pharmaceuticals Inc. 1-piperidinyl alkanoylanyl sulfonamides for treatment of cardiac arrhythmia
NZ239846A (en) * 1990-09-27 1994-11-25 Merck & Co Inc Sulphonamide derivatives and pharmaceutical compositions thereof
US5202346A (en) * 1992-02-25 1993-04-13 American Home Products Corporation Piperidinyl and piperazinyl derivatives
US5254689A (en) * 1992-02-25 1993-10-19 American Home Products Corporation Piperdinyl and piperazinyl derivatives
WO1999038827A1 (en) * 1998-02-02 1999-08-05 Merck & Co., Inc. PLATELET AGGREGATION INHIBITION USING LOW MOLECULAR WEIGHT HEPARIN IN COMBINATION WITH A GP IIb/IIIa ANTAGONIST
US6136794A (en) * 1998-02-02 2000-10-24 Merck & Co., Inc. Platelet aggregation inhibition using low molecular weight heparin in combination with a GP IIb/IIIa antagonist
GB9901147D0 (en) * 1999-01-19 1999-03-10 Merck Sharp & Dohme Therapeutic agents
DE10000739A1 (de) * 2000-01-11 2001-07-12 Merck Patent Gmbh Piperidin- und Piperazinderivate
US7408067B2 (en) 2002-01-17 2008-08-05 Merck + Co., Inc. Aza-cyclic compounds as modulators of acetylcholine receptors
GB0326221D0 (en) 2003-11-10 2003-12-17 Merck Sharp & Dohme Therapeutic agents,compositions,preparations and uses
GB0419192D0 (en) * 2004-08-27 2004-09-29 Merck Sharp & Dohme Therapeutic agents
GB0426313D0 (en) * 2004-12-01 2005-01-05 Merck Sharp & Dohme Therapeutic agents
US9051296B2 (en) 2009-11-16 2015-06-09 Raqualia Pharma Inc. Aryl carboxamide derivatives as TTX-S blockers
WO2015040352A1 (en) * 2013-09-18 2015-03-26 Redx Pharma Limited Agricultural chemicals

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB993584A (el) * 1962-01-24
US3968242A (en) * 1974-08-26 1976-07-06 Mead Johnson & Company Sulfonamidoaminopropiophenone interceptive process
US4044150A (en) * 1976-06-18 1977-08-23 Mead Johnson & Company Antihypertensive 4'-[1-hydroxy-2-[(1-phenoxy ethyl)-amino]ethyl]methanesulfonanilide and salts thereof and therapeutic use
DE3306697A1 (de) * 1983-02-25 1984-08-30 Bayer Ag, 5090 Leverkusen Substituierte maleinsaeureimide
US4544654A (en) * 1984-03-20 1985-10-01 Schering A.G. Substituted sulfonamidobenzamides, antiarrhythmic agents and compositions thereof
PH23283A (en) * 1986-02-26 1989-06-30 Eisai Co Ltd Piperidine derivative, pharmaceutical composition containing the same and method of use thereof

Also Published As

Publication number Publication date
GR3006380T3 (el) 1993-06-21
PH25458A (en) 1991-07-01
DE3875866D1 (de) 1992-12-17
CA1263658A (en) 1989-12-05
US5082850A (en) 1992-01-21
NO883750D0 (no) 1988-08-22
HUT48587A (en) 1989-06-28
EP0304888A1 (en) 1989-03-01
KR890003691A (ko) 1989-04-17
DK470488D0 (da) 1988-08-23
US4977165A (en) 1990-12-11
DE3875866T2 (de) 1993-04-15
DK470488A (da) 1989-02-25
ES2045044T3 (es) 1994-01-16
EP0304888B1 (en) 1992-11-11
NO883750L (no) 1989-02-27
KR910002581B1 (ko) 1991-04-27

Similar Documents

Publication Publication Date Title
HU207043B (en) Process for producing sulfonamide derivatives and pharmaceutical compositions comprising such compounds
JP3176365B2 (ja) ベンゼンスルホンアミド誘導体
US5021436A (en) 2-thiomethyl-substituted-1,4-dihydropyridines, and pharmaceutical compositions containing same and antihypertensive properties
US5208243A (en) 5-isoquinolinesulfonamides
SK4796A3 (en) Tri-substituted imidazoles, manufacturing process thereof, pharmaceutical agent containing them and their use
EP0266922A1 (en) Dihydropyridine derivatives, their preparation and their use
FR2758559A1 (fr) Composes inhibant les metalloproteases
FR2581993A1 (fr) Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique
HU195804B (en) Process for preparing piperidine derivatives and medical compositions containing them
US4866196A (en) Phenoxyacetic acid derivatives and preparation thereof
US4857644A (en) Aryl sulfonopiperazines as anti-inflammatory agents
FR2566404A1 (fr) Nouveaux derives de la 1,4-dihydropyridine, leurs sels, procede pour les preparer, et compositions pharmaceutiques les contenant
US6350766B1 (en) Dihydropyridine derivative
JP4623354B2 (ja) 新規ピリミジン誘導体及び新規ピリジン誘導体
HU196200B (en) Process for producing diphenyl-piperidine derivatives and pharmaceutical compositions containing them
JPH0390062A (ja) 置換ｎ―（キノリン―２―イル―メトキシ）ベンジルスルホニルウレア
JPS61282359A (ja) Ｎ−ベンジル−ピペリジン化合物およびそれを含有する医薬組成物
US5314885A (en) Cyclic benzylamino, benzylamido, and benzylimido antipsychotic agents
HUT52055A (en) Process for producing basic 4-aryl-dihydropyridin-amides and pharmaceutical compositions containing them
DE602004005863T2 (de) 4-arylsulphonylpiperidin-derivate als 5-ht2a -rezeptor antagonisten
US4731370A (en) Pyridyl ester containing 1,4-dihydropyridine derivatives and salts thereof and pharmaceutical composition containing the same
JPH0720954B2 (ja) 新規なｎ−（イソキノリン−５−イルスルホニル）アザシクロアルカン化合物
US5162347A (en) Piperidine derivatives and therapeutic and preventive agents for arrhythmia containing same
US5246946A (en) Piperidine derivatives and therapeutic and preventive agents for arrhythmia containing same
US4029786A (en) Morpholine derivatives for treating depression

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee